U.S. FDA Recommends Additional Clinical Trial for ABL Bio's Biliary Tract Cancer Drug, Clouding Approval Timeline
U.S. FDA Recommends Additional Clinical Trial for ABL Bio's Biliary Tract Cancer Drug, Clouding Approval Timeline finance.biggo.com
U.S. FDA Recommends Additional Clinical Trial for ABL Bio's Biliary Tract Cancer Drug, Clouding Approval Timeline finance.biggo.com
Many patients with early-stage breast cancer do not consistently maintain the long-term hormone therapy prescribed after lumpectomy, a large U.S. insurance claims analysis indicates. The findings provide real-world context for treatment approaches that consider omitting radiation therapy, which typically rely on the…
Главный онколог РФ рассказал как снизить риск рака на 30% без лекарств Веселовские Вести
Около 1 700 неизвестных белков нашли в «мусорной» ДНК — и уже сделали из них вакцину от рака ixbt.com
«Лечат» рак уксусом и голодом: врачи предупредили об опасной моде на советы блогеров Life.ru
AI Tells Doctors When It Is Unsure About Cancer Treatment Success Bioengineer.org
Рак поджелудочной и наследственность, кому нужен генетический тест и скрининг SecurityLab.ru
Gold Nanorods and Laser Light Strike at Cancer Stem Cells in Cats With Breast Tumors Bioengineer.org
Do Pharmaceutical Payments Influence Cancer Treatment Decisions? – RioOncology Oncodaily
Mark Lawler Discusses the Lancet Oncology Commission on Genomics and Precision Oncology in New Podcast Oncodaily
Firas Transforms His Childhood Cancer Journey Into Hope for Others - King Hussein Cancer Foundation and Center Oncodaily
Enrique Soto Perez Announces Publication of Global Patient Navigation Study in JCO Global Oncology Oncodaily
“I cannot imagine a better candidate for this important global position! He is a tireless advocate for patients everywhere.” - Renowned oncologist and researcher Dr Elad Sharon endorses WHO Director-General candidate Dr Gevorg Tamamyan. Oncodaily
“For years Dr Gevorg Tamamyan is proving that even with limited access, world class medicine is possible” - President of Kazakhstan Cancer Society supports Dr Gevorg Tamamyan as WHO Director-General candidate Oncodaily
FDA Approves New First-Line Treatment Options for HER2-Positive AdvancedGastric and GEJ Cancer news.cancerconnect.com